Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PSMB1 | P20618 | 1/20 | 0.40 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.40 |
| ▸ | ACACB | O00763 | 3/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | FKBP1A | P62942 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9814589 | 0.82 | PSMB1 (0.43) | PSMB1PSMB5ACACBMEN1KMT2A | |
| SCHEMBL10299206 | 0.80 | PSMB1 (0.36) | PSMB1PSMB5ACACBKMT2AALDH1A1 | |
| SCHEMBL10022970 | 0.79 | IDO1 (0.33) | — | |
| SCHEMBL12855824 | 0.74 | ABCB11 (0.33) | — | |
| SCHEMBL12855817 | 0.74 | ESR1 (0.31) | ACACBALDH1A1 | |
| SCHEMBL13498028 | 0.67 | KMT2A (0.41) | MEN1KMT2AFKBP1A | |
| SCHEMBL26806297 | 0.66 | ACACB (0.47) | ACACBCYP1A2CYP3A4GAACYP2C9 | |
| SCHEMBL12203937 | 0.66 | NQO1 (0.67) | PSMB1PSMB5ACACBALDH1A1 | |
| SCHEMBL4461068 | 0.64 | DRD2 (0.40) | CYP1A2CYP3A4GAACYP2C9CYP2C19 | |
| SCHEMBL2836200 | 0.64 | ALDH1A1 (0.36) | ACACBCYP1A2CYP3A4CYP2C9CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8932797-B2 | Photoacid generators | DOW GLOBAL TECHNOLOGIES LLC (US) | 2015-01-13 | — | — | US | disclosed |
| US-8907122-B2 | Method of preparing photoacid generating monomer | ROHM AND HAAS ELECTRONIC MATERIAL LLC (US) | 2014-12-09 | — | — | US | disclosed |
| US-8716518-B2 | Photoacid generating monomer and precursor thereof | ROHM AND HAAS ELECTRONIC MATERIALS LLC (US) | 2014-05-06 | — | — | US | disclosed |
| US-20120172555-A1 | PHOTOACID GENERATING MONOMER AND PRECURSOR THEREOF | DOW GLOBAL TECHNOLOGIES LLC | 2012-07-05 | — | — | US | disclosed |
| US-20120172619-A1 | METHOD OF PREPARING PHOTOACID GENERATING MONOMER | ROHM AND HAAS ELECTRONIC MATERIALS LLC | 2012-07-05 | — | — | US | disclosed |
| US-20120141939-A1 | PHOTOACID GENERATORS | U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS NOTES COLLATERAL AGENT | 2012-06-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120141939-A1 | PHOTOACID GENERATORS | F10, GNG2, H1-0 | PSMB1 1568/4885PSMB5 1905/4885ACACB 2715/4885 |
| US-20120172555-A1 | PHOTOACID GENERATING MONOMER AND PRECURSOR THEREOF | SULT1A1, SULT1E1, SULT2A1 | PSMB1 2168/4885PSMB5 1919/4885ACACB 4142/4885 |
| US-20120172619-A1 | METHOD OF PREPARING PHOTOACID GENERATING MONOMER | POLL, SULT1A1, SULT1E1 | PSMB1 2189/4885PSMB5 2588/4885ACACB 3411/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.